Summary of Proceeding of EGM
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rekvina Laboratories held its first EGM of FY2026-27 on April 10, 2026, at its registered office in Vadodara, from 11:30 AM to 11:50 AM. A total of 17 members attended in person, and the meeting was chaired by Managing Director Mr. Amit Mukesh Shah. Six special business items were placed before members for approval, including an increase in authorised share capital with corresponding amendment to the MOA, alteration of Articles of Association, raising Section 186 limits for investments/loans/guarantees, approval of related party transactions, and two separate preferential equity issues — one for non-cash consideration and one for cash to non-promoters. Members raised queries about the company's fund-raising plans, which the MD addressed. Voting was conducted through polling papers under the supervision of Scrutinizer Mr. Suhas Bhattbhatt; results are pending in a separate report.
If approved, these resolutions would allow the company to raise fresh capital via preferential issues and modify its capital and governance framework. The actual voting outcomes, still awaited from the Scrutinizer, are the key trigger — successful passage would enable potential equity dilution for existing shareholders and define the size of the fund-raise.